Imaging Recommendations for Mixed Hearing Loss

Indications for Imaging

Mixed hearing loss should be evaluated with either non‑contrast CT of the temporal bone or MRI of the head and internal auditory canal (with or without contrast), as recommended by the American College of Radiology. 1

CT without IV contrast is the preferred modality to assess the conductive component, providing detailed visualization of otosclerotic changes in the otic capsule, the most common cause of mixed hearing loss. 2
CT also reliably depicts middle‑ear structural pathology (e.g., ossicular chain abnormalities) and temporal‑bone fractures in post‑traumatic cases. [2][3]

MRI with a dedicated IAC protocol is required to exclude retro‑cochlear pathology responsible for the sensorineural component, including vestibular schwannomas, labyrinthitis/neuritis (enhanced with contrast), and other intracanalicular or cerebellopontine‑angle lesions. 3

Initial CT is indicated when clinical suspicion primarily points to a conductive etiology or when otosclerosis is suspected based on a progressive conductive or mixed loss pattern. [1][2]
Add MRI when CT findings do not fully explain the clinical picture, ensuring retro‑cochlear disease is not missed. 3
Combined CT + MRI should be performed for comprehensive presurgical planning of the conductive component. 1

CT is insensitive for soft‑tissue lesions that cause sensorineural loss (e.g., small vestibular schwannomas, labyrinthitis, intracanalicular tumors). 3
CT of the head is markedly less sensitive than MRI for detecting or excluding retro‑cochlear pathology. 2
MRI is less effective than CT for visualizing bony structures essential to diagnosing conductive disease, such as otosclerotic fenestral and retrofenestral changes and superior semicircular canal dehiscence. 2
MRI also has limited ability to detect temporal‑bone fractures compared with CT. 3

IV contrast is generally unnecessary for CT temporal‑bone assessment and does not improve diagnostic yield. 2
IV contrast in MRI IAC protocols enhances detection of inflammatory changes and neoplasms (e.g., labyrinthitis, neuritis, vestibular schwannoma), but current evidence does not demonstrate a clear incremental benefit over non‑contrast MRI for routine screening. 2
Punctate enhancement within the otic capsule on contrast‑enhanced MRI may be observed in otosclerosis. 3

MRA, MRV, and CTA have no supporting evidence for use in the initial evaluation of mixed hearing loss and should be avoided. 2

The American Academy of Otolaryngology-Head and Neck Surgery recommends comprehensive audiometry with air and bone conduction thresholds to quantify both the conductive and sensorineural components of mixed hearing loss 4, 5
Otoscopic examination is necessary to identify treatable conductive pathology, such as cerumen impaction, middle ear effusion, tympanic membrane perforation, or cholesteatoma 4, 6
Tympanometry is used to assess middle ear function and guide surgical candidacy 7

The conductive component of mixed hearing loss should be treated initially, as it is often reversible, with cerumen removal, medical management for middle ear effusion or otitis media, or surgical intervention for structural abnormalities 4, 7
The American Academy of Otolaryngology-Head and Neck Surgery recommends CT temporal bone imaging to delineate otosclerosis changes, identify ossicular chain abnormalities, and plan surgical approach for conductive pathology 8
MRI with internal auditory canal protocol should be obtained if asymmetric or unilateral sensorineural component is present, or if sudden onset of the sensorineural component occurred 8, 9, 10

Audiologic rehabilitation with hearing aids fitted by an audiologist is recommended for moderate to severe residual sensorineural loss 9, 10
The American Academy of Otolaryngology-Head and Neck Surgery recommends oral corticosteroids within 2 weeks of onset as initial therapy for sudden sensorineural hearing loss 9, 10, 11

Follow-up audiometry should be obtained within 6 months after initial treatment to document hearing outcomes and guide further intervention 12
Reassessment of hearing after surgical correction of the conductive component is necessary to confirm resolution and quantify residual sensorineural loss 7

The American Academy of Otolaryngology-Head and Neck Surgery advises against assuming all hearing loss is purely conductive without formal audiometry, as this can delay appropriate treatment 4, 5, 6
Routine CT head or laboratory tests for the sensorineural component should not be ordered unless systemic illness is suspected, as they have low diagnostic yield 9, 10